BANK OF AMERICA CORP /DE/
BankPosition in XENE — Xenon Pharmaceuticals Inc.
CIK 70858
CHARLOTTE, NC
Position in XENE
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$15,425,274
+$5,503,563 QoQ
Shares Held
265,267
+19.8% QoQ
Ownership
0.274%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 56.462733773895735.ToString("F0")%
Shared 0.ToString("F0")%
None 43.537266226104265.ToString("F0")%
Common Shares in XENE Over Time
Shares Held
Position Value (USD)
Derivatives in XENE
reported options exposure · as of Dec 31, 2023CallValue
$5,384,414
CallShares
116,900
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF AMERICA CORP /DE/ holds $8,548,750,242 across 347 Biotechnology names. XENE ranks #85 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,878,183 | $1,285,223,834 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,189,584 | $919,120,177 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
966,912 | $319,922,169 | |
| 4 | ARGX |
Argenx SE
|
400,117 | $292,185,437 | |
| 5 | INSM |
INSMED Inc
|
1,502,281 | $245,652,986 | |
| 6 | CYTK |
Cytokinetics Inc
|
3,125,436 | $205,997,485 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,014,800 | $191,847,936 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,913,109 | $188,274,232 |
All Filings in XENE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $15,425,274 | 265,267 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $9,921,711 | 221,368 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $7,994,103 | 199,106 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $11,218,919 | 358,432 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $4,581,887 | 136,569 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $4,190,713 | 106,906 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $5,017,940 | 127,456 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $5,549,522 | 142,332 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $6,763,325 | 157,104 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $6,144,954 | 133,412 | Shares | Defined | 2024-02-14 | |
| 2023-12-31 | $5,384,414 | 116,900 | Call | Defined | 2024-02-14 | |
| 2023-09-30 | $4,234,710 | 123,967 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $6,135,975 | 159,376 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $4,799,831 | 134,111 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $3,499,332 | 88,748 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $974,518 | 26,995 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,115,043 | 36,655 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $191,948 | 6,279 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,337,008 | 42,798 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $219,832 | 14,387 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $129,947 | 6,979 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $309,167 | 17,272 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $43,955 | 2,858 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $37,006 | 3,343 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $44,266 | 3,530 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||